Recombinant Human NFIB Protein，His & GST

NFIB (Nuclear Factor I B) is a transcription factor that plays a pivotal role in various biological processes, including cellular development, differentiation, and response to stress. Research into NFIB has gained momentum due to its implications in several diseases, particularly in cancer. Studies have shown that NFIB is aberrantly expressed in various tumor types, contributing to oncogenesis by promoting cell proliferation, survival, and migration. Additionally, NFIB interacts with other signaling pathways and transcription factors, influencing the tumor microenvironment and immune response. Given its involvement in these critical mechanisms, NFIB has emerged as a potential therapeutic target, prompting investigations into its structure, function, and regulatory networks. Understanding the molecular mechanisms of NFIB could lead to novel strategies for cancer treatment and shed light on its role in normal physiology and disease. Researchers are employing various techniques, including molecular biology, genomics, and bioinformatics, to unravel NFIB's complex regulatory roles and identify downstream targets that may provide insight into its therapeutic potential. The ongoing studies focus on defining the specific contexts in which NFIB acts, how its activity is regulated, and its interactions with other cellular components, which are crucial for developing targeted interventions in diseases characterized by NFIB dysregulation. This research not only expands our understanding of NFIB's biological functions but also enhances the potential for developing innovative treatment strategies for cancer and other NFIB-related disorders.